Indica Labs Announces Third Webinar for February
Date: 29 February 2024
Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT
Location: Webinar
Summary
A new version of HALO AI is coming soon! This webinar is your chance to get a look at the exciting new features and functionalities packed into the latest HALO AI release. Donald Allen will guide you through a comprehensive demonstration, highlighting features to streamline your digital pathology workflow and empower your image analysis. See new AI workflows, such as our new AI Annotation Tool or the Classifier Pipeline for chaining classifiers, learn more about our new FL membrane segmentation model, and more.
Learning Objectives
- Get familiar with the new features and functionalities in HALO AI 4.0
- Learn how you can benefit from the updated and expanded offering of pre-trained AI models
- Learn about quality-of-life updates that enhance your productivity\
Additional Webinars for the Life Sciences 4.0 Release:
Presenter
Donald Allen
Product Manager, HALO AI
Indica Labs
Donald Allen earned his BS in Microbiology, Immunology, and Molecular Genetics from UCLA. He has over 5 years of experience in R&D with Dako/Agilent in the field of companion diagnostics. He is experienced in feasibility of Class III medical device development, deployment of clinical trial assays to CROs, and the development of manual scoring algorithms. Donald now works in the field of digital pathology and image analysis to combine his work experience and his passion for computers and technology. He joined Indica Labs as an Applications Scientist in 2017, was promoted to a Sr. Applications Scientist in 2020, and most recently was promoted to the role of HALO AI Product Manager.
SOURCE: Indica Labs
- Related Categories:
- Artificial Intelligence
- Digital Pathology News
- Education
- Image Analysis
- Webinars
next article
Biofidelity: Fast, simple, decentralized testing from tissue and blood using standard PCR instruments New data to be presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA and RNA CAMBRIDGE,...